BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005 [PMID: 26973395 DOI: 10.3748/wjg.v22.i10.2993]
URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2993.htm
Number Citing Articles
1
Yongrok Jeong, Jaeho Park, Jinwoo Lee, Kyuyoung Kim, Inkyu Park. Ultrathin, Biocompatible, and Flexible Pressure Sensor with a Wide Pressure Range and Its Biomedical ApplicationACS Sensors 2020; 5(2): 481 doi: 10.1021/acssensors.9b02260
2
Jing Sun, Aimin Zhang, Wengang Li, Quan Wang, Jia Wang, Yuze Fan, Yingzhe Sun, Dong Li, Dan Zhang, Xuezhang Duan. CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated CirrhosisFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00100
3
Keizo Kato, Hiroshi Abe, Makiko Ika, Takeshi Yonezawa, Yoshiyuki Sato, Noriko Hanawa, Shohei Shimizu, Shinji Endo, Ryota Matsuo, Akihito Tsubota. C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular CarcinomaOncology 2017; 92(3): 142 doi: 10.1159/000453665
4
Yuan-Hung Kuo, Tzu-Hsin Huang, Yi-Hao Yen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Ming-Chao Tsai, Kwong-Ming Kee. Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency AblationCancers 2023; 15(12): 3156 doi: 10.3390/cancers15123156
5
Garrett Richard Roll, John Paul Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set2019; : 1541 doi: 10.1016/B978-0-323-40232-3.00132-1
6
Xiu-Mei Bai, Zhong-Hu He, Hao Wu, Wei Yang, Song Wang, Zhong-Yi Zhang, Wei Wu, Kun Yan, Min-Hua Chen, S. Nahum Goldberg. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatmentEuropean Journal of Radiology 2023; 168: 111094 doi: 10.1016/j.ejrad.2023.111094
7
Xu-Hua Duan, Hao Li, Xin-Wei Han, Jian-Zhuang Ren, Feng-Yao Li, Shu-Guang Ju, Peng-Fei Chen, Dong-Lin Kuang. Upregulation of IL-6 is involved in moderate hyperthermia induced proliferation and invasion of hepatocellular carcinoma cellsEuropean Journal of Pharmacology 2018; 833: 230 doi: 10.1016/j.ejphar.2018.06.014
8
Xiu-Mei Bai, Wei Yang. Radiofrequency ablation of hepatocellular carcinoma: Prognostic factors and recent advancesWorld Chinese Journal of Digestology 2021; 29(13): 677 doi: 10.11569/wcjd.v29.i13.677
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
9
Peikun Li, Zhongshan Yu, Liang He, Dachen Zhou, Shengxue Xie, Hui Hou, Xiaoping Geng. Knockdown of FOXK1 inhibited the proliferation, migration and invasion in hepatocellular carcinoma cellsBiomedicine & Pharmacotherapy 2017; 92: 270 doi: 10.1016/j.biopha.2017.05.087
10
Mauro Giuffrè, Enrico Zuliani, Alessia Visintin, Paola Tarchi, Paola Martingano, Riccardo Pizzolato, Deborah Bonazza, Flora Masutti, Rita Moretti, Lory Saveria Crocè. Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center ExperienceDiagnostics 2022; 12(10): 2517 doi: 10.3390/diagnostics12102517
11
Zheng Fang, Bing Zhang, Wenjun Zhang. Advanced Computational Methods in Life System Modeling and SimulationCommunications in Computer and Information Science 2017; 761: 113 doi: 10.1007/978-981-10-6370-1_12
12
Jagpreet Chhatwal, Ali Hajjar, Peter P. Mueller, Gizem Nemutlu, Neeti Kulkarni, Mary Linton B. Peters, Fasiha Kanwal. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C IndividualsClinical Gastroenterology and Hepatology 2024; 22(1): 91 doi: 10.1016/j.cgh.2023.05.024
13
Yu-qing Du, Xiu-mei Bai, Wei Yang, Zhong-yi Zhang, Song Wang, Wei Wu, Kun Yan, Min-hua Chen. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinomaInternational Journal of Hyperthermia 2022; 39(1): 517 doi: 10.1080/02656736.2022.2048907
14
Jakob Weiss, Rüdiger Hoffmann, Hansjoerg Rempp, David‐Emanuel Keβler, Philippe L. Pereira, Konstantin Nikolaou, Stephan Clasen. Feasibility, efficacy, and safety of percutaneous MR‐guided ablation of small (≤12 mm) hepatic malignanciesJournal of Magnetic Resonance Imaging 2019; 49(2): 374 doi: 10.1002/jmri.26252
15
Peter P. Mueller, Qiushi Chen, Turgay Ayer, Gizem S. Nemutlu, Ali Hajjar, Emily D. Bethea, Mary Linton B. Peters, Brian P. Lee, Naveed Z. Janjua, Fasiha Kanwal, Jagpreet Chhatwal. Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradicationJournal of Hepatology 2022; 77(1): 55 doi: 10.1016/j.jhep.2022.01.027
16
Fanyu Meng, Haoyun Zhang, Haiwen Peng, Shichun Lu, Min Tang. Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different TreatmentsBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6638117
17
Mingheng Liao, Xiaofei Zhong, Jingyi Zhang, Yangyang Liu, Zexin Zhu, Hong Wu, Yong Zeng, Jiwei Huang. Radiofrequency ablation using a 10‐mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trialJournal of Surgical Oncology 2017; 115(8): 971 doi: 10.1002/jso.24607
18
Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis R. Roberts, Mindie H. Nguyen, A. Burak Ozbay, Turgay Ayer, Neehar D. Parikh, Amit G. Singal. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling studyHepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000146
19
Valtteri KAIRALUOMA, Mira KARJALAINEN, Vesa-Matti POHJANEN, Juha SAARNIO, Jarmo NIEMELÄ, Heikki HUHTA, Olli HELMINEN. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 yearsMinerva Surgery 2021; 76(3) doi: 10.23736/S2724-5691.21.08426-1
20
Jeong Hee Yoon, Won Chang, Eun Sun Lee, Sang Min Lee, Jeong Min Lee. Double Low-Dose Dual-Energy Liver CT in Patients at High-Risk of HCCInvestigative Radiology 2020; 55(6): 340 doi: 10.1097/RLI.0000000000000643
21
Genevieve Jingwen Tan, Chau Hung Lee, Yan Sun, Cher Heng Tan. Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?Singapore Medical Journal 2024; 65(1): 23 doi: 10.11622/smedj.2021153
22
Wei-Yu Kao, Chien-Wei Su, Yi-You Chiou, Nai-Chi Chiu, Chien-An Liu, Kuan-Chieh Fang, Teh-Ia Huo, Yi-Hsiang Huang, Chun-Chao Chang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency AblationRadiology 2017; 285(2): 670 doi: 10.1148/radiol.2017162382
23
Zhong-Xing Shi, Chang-Fu Li, Li-Feng Zhao, Zhong-Qi Sun, Li-Ming Cui, Yan-Jie Xin, Dong-Qing Wang, Tan-Rong Kang, Hui-Jie Jiang. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2023;  doi: 10.1016/j.hbpd.2023.06.011
24
Dimitrios S. Karagiannakis. Systemic Treatment in Intermediate Stage (Barcelona Clinic Liver Cancer-B) Hepatocellular CarcinomaCancers 2023; 16(1): 51 doi: 10.3390/cancers16010051
25
Ashwin Shinde, Bernard L. Jones, Yi-Jen Chen, Arya Amini. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?Journal of Clinical Oncology 2018; 36(24): 2566 doi: 10.1200/JCO.2018.78.6012
26
Delia D’Avola, Alessandro Granito, Manuel de la Torre-Aláez, Fabio Piscaglia. The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinomaJournal of Hepatology 2022; 76(5): 1185 doi: 10.1016/j.jhep.2021.11.013
27
Qingsong Deng, Minglian He, Chunchuan Fu, Kai Feng, Kuansheng Ma, Leida Zhang. Radiofrequency ablation in the treatment of hepatocellular carcinomaInternational Journal of Hyperthermia 2022; 39(1): 1052 doi: 10.1080/02656736.2022.2059581
28
Yuanfeng Meng, Binbin Jiang, Kun Yan, Song Wang, Zhongyi Zhang, Luzeng Chen, Wei Wu, Wei Yang. Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladderInternational Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2023.2182748
29
Jin-Yu Wu, Xiu-Mei Bai, Hong Wang, Qian Xu, Song Wang, Wei Wu, Kun Yan, Wei Yang. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial TumorsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01464
30
Jing-Jing Fu, Song Wang, Wei Yang, Wei Gong, An-Na Jiang, Kun Yan, Min-Hua Chen. Protective and Heat Retention Effects of Thermo-sensitive Basement Membrane Extract (Matrigel) in Hepatic Radiofrequency Ablation in an Experimental Animal StudyCardioVascular and Interventional Radiology 2017; 40(7): 1077 doi: 10.1007/s00270-017-1617-1
31
Riccardo Memeo, Patrick Pessaux, Nicola Silvestris, Oronzo Brunetti, Antonio Giovanni Solimando, Andrea Casadei Gardini. Practical Medical Oncology TextbookUNIPA Springer Series 2021; : 689 doi: 10.1007/978-3-030-56051-5_42
32
Anh Le Tuan Nguyen, Christopher Leigh Blizzard, Kwang Chien Yee, Julie A. Campbell, Andrew J. Palmer, Barbara de Graaff. Hospitalisation costs of primary liver cancer in Australia: evidence from a data-linkage studyAustralian Health Review 2022; 46(4): 463 doi: 10.1071/AH21395
33
Hyo-Jin Kang, Jeong Min Lee, Chulkyun Ahn, Jae Seok Bae, Seungchul Han, Se Woo Kim, Jeong Hee Yoon, Joon Koo Han. Low dose of contrast agent and low radiation liver computed tomography with deep-learning-based contrast boosting model in participants at high-risk for hepatocellular carcinoma: prospective, randomized, double-blind studyEuropean Radiology 2023; 33(5): 3660 doi: 10.1007/s00330-023-09520-4
34
Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Yasser H. El-Sharkawy. Tissue characterization utilizing hyperspectral imaging for liver thermal ablationPhotodiagnosis and Photodynamic Therapy 2020; 31: 101899 doi: 10.1016/j.pdpdt.2020.101899
35
Yun Mou, Qiyu Zhao, Liyun Zhong, Fen Chen, Tianan Jiang. Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodesWorld Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0917-2
36
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaCritical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
37
Zhi‐Yuan Chen, Zhi‐Xing Guo, Liang‐He Lu, Jie Mei, Wen‐Ping Lin, Shao‐Hua Li, Wei Wei, Rong‐Ping Guo. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinomaCancer Medicine 2021; 10(16): 5466 doi: 10.1002/cam4.4102
38
B. I. Dolgushin, V. Yu. Kosyrev, E. R. Virshke, V. N. Sholokhov, D. V. Martynkov. Radiofrequency thermal destruction in current treatment of liver malignancies. Literature reviewAnnaly khirurgicheskoy gepatologii = Annals of HPB surgery 2018; 23(2): 11 doi: 10.16931/1995-5464.2018211-25
39
Yong Zhu He, Kun He, Rui Qin Huang, Li Wen Liu, Shao Wei Ye, Jun Lin Qian, Peng Peng, Qi Jie Luo, Ze Liang Wang, Ze Min Hu. A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87782-y
40
Ahmed Salman, Mohamed Salman, Ahmed Moustafa, Hossam El-Din Shaaban, Ahmed El-Mikkawy, Safa Labib, Ahmed Youssef, Mahmoud Gouda Omar, Mohamed Matter, Hesham Elkassar. Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency AblationJournal of Hepatocellular Carcinoma 2021; : 313 doi: 10.2147/JHC.S300680
41
Amar Mukund, Prayas Vats, Ankur Jindal, Yashwant Patidar, Shiv K. Sarin. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation—Mid- and Long-Term OutcomesJournal of Clinical and Experimental Hepatology 2020; 10(6): 563 doi: 10.1016/j.jceh.2020.04.016
42
Pantzios Spyridon, Syriha Antonia, Mandilara Dionysia, Stathopoulou Ioanna, Barla Georgia, Ptohis Nikolaos, Galanis Petros, Elefsiniotis Ioannis. Efficacy of Αtezolizumab–Βevacizumab in BCLC-C cirrhotic patients with hepatocellular carcinoma according to the type of disease progression, the type of BCLC-C and liver disease severityJournal of Cancer Research and Clinical Oncology 2023; 149(11): 9253 doi: 10.1007/s00432-023-04846-4
43
Wei Yang, Kun Yan, Min-Hua Chen, Jin-Yu Wu, Zhong-Yi Zhang, Jung-Chieh Lee, Song Wang, Wei Wu. Preliminary experience with direct percutaneous arterial embolisation combined with radiofrequency ablation for hypervascular HCCInternational Journal of Hyperthermia 2017; : 1 doi: 10.1080/02656736.2017.1305126
44
Alessandro Granito, Luigi Bolondi. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosisThe Lancet Oncology 2017; 18(2): e101 doi: 10.1016/S1470-2045(16)30569-1
45
Xiu-Mei Bai, Ming Cui, Wei Yang, Hong Wang, Song Wang, Zhong-Yi Zhang, Wei Wu, Min-Hua Chen, Kun Yan, S. Nahum Goldberg. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCCRadiology 2021; 300(2): 458 doi: 10.1148/radiol.2021200153
46
Shicheng Zhou, Terrence Chi Hong Hui, Uei Pua. Percutaneous thermal ablation of hepatocellular carcinoma in the older populationJournal of Geriatric Oncology 2020; 11(7): 1161 doi: 10.1016/j.jgo.2020.03.004
47
Jingru Pan, Xianlong Li, Ye He, Chaojun Jian, Hui-xin Chen, Ziqing Hei, Shaoli Zhou. Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trialTrials 2019; 20(1) doi: 10.1186/s13063-018-3010-z
48
Carlos Moctezuma-Velazquez, Aldo J. Montano-Loza, Judith Meza-Junco, Kelly Burak, Mang Ma, Vincent G. Bain, Norman Kneteman, Phillipe Sarlieve, Richard J. Owen. Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer StagesDigestive Diseases and Sciences 2021; 66(3): 899 doi: 10.1007/s10620-020-06245-y
49
Wan Yee Lau, Stephanie Hiu Yan Lau. The current role of radiofrequency ablation in the treatment of hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2017; 16(2): 122 doi: 10.1016/S1499-3872(16)60182-0
50
Xue-Song Yao, Dong Yan, Xian-Xian Jiang, Xiao Li, Hui-Ying Zeng, Huai Li. Short-term outcomes of radiofrequency ablation for hepatocellular carcinoma using cone-beam computed tomography for planning and image guidanceWorld Journal of Clinical Cases 2021; 9(7): 1580-1591 doi: 10.12998/wjcc.v9.i7.1580
51
Jeffrey L. Weinstein, Muneeb Ahmed. Percutaneous Ablation for Hepatocellular CarcinomaAmerican Journal of Roentgenology 2018; 210(6): 1368 doi: 10.2214/AJR.17.18695